🇺🇸 FDA
Patent

US 9856241

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

granted A61PA61P1/02A61P1/04

Quick answer

US patent 9856241 (Substituted benzofuranyl and benzoxazolyl compounds and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18